Drug sensitivity analysis is crucial for precision cancer therapy. We developed CPADS, a web tool integrating transcriptomic data from 29,000+ samples (44 cancers, 288 drugs, 9,000+ gene perturbations ...

Over 100 prominent companies are currently engaged in developing treatments for osteoarthritis. Among them, Biosplice Therapeutics has drug candidates that have reached the most advanced stage—Phase ...